All right, let’s take *** look panel. Robinson has used corrective lenses since first grade. Now working as *** cinematographer and director. His contacts had become *** constant misery. The inflammation from wearing them for super long hours was making my vision *** little blurry. My eyes get super dry and it was just getting sort of unsustainable to help correct his vision and ditches contact lenses. His eye doctor suggested *** procedure known as EVO vision. The EVO is *** permanent implantable contact lens that’s placed in the eye instead of *** contact lens that you would wear on the surface of the eye where you have to constantly take out and put back in dr nettles. Shammy is an ophthalmologist with the maloney shammy Vision Institute. She says the procedure is ideal for treating myopia, otherwise known as nearsightedness and offers an alternative to LASIK surgery, which works by changing the anatomy of the eye. The Evo Vision I procedure has been approved overseas for 10 years with more than *** million surgeries performed here in the United States. It was approved by the FDA in late March. It hits the market just as I complaints are soaring. Myopia is increasing so rapidly. An international study estimates half the global population could be nearsighted in the next 30 years. This is the best you could see without your glasses and contact lenses. Prior to surgery, The implants take just 8-10 minutes per eye and the improvement is nearly immediate. It’s pretty weird to wake up in the morning and just see *** new window on the world, which Robinson describes as life changing Danya, Bacchus, CBS, News, Los Angeles.
Advertisement
New eye surgery offers patients implantable contact lenses
The pandemic has brought a significant increase in vision complaints, partly fueled during the pandemic as people spent more time than ever staring at screens.
Updated: 4:07 PM CDT Jul 17, 2022
The pandemic has brought a significant increase in vision complaints, partly fueled during the pandemic as people spent more time than ever staring at screens. The surge in nearsightedness, or myopia, is creating more interest in vision correction procedures and a recent innovation is attracting attention: an implantable contact lens, which was ideal for Powell Robinson, who has been using contact lenses since seventh grade. “Basically, the inflammation from wearing them for super long hours made my vision get a little blurry, my eyes would get super dry, and it was just getting sort of unsustainable,” Robinson said. Working as a cinematographer and director in Los Angeles, he went to Dr. Neda Shamie at the Malone-Shamie Vision Institute for help. She recommended a procedure known as EVO Visian ICL. “The Evo ICL is a permanent implantable contact lens that’s placed in the eye instead of a contact lens that you would wear on the surface of the eye, where you have to constantly take out and put back in,” Shamie said.She said that the implant is ideal for treating nearsightedness and offers an alternative to Lasik surgery, which works by changing the anatomy of the eye. The Evo Visian ICL has been approved overseas for more than 10 years with more than a million surgeries performed. Here in the United States, it was approved by the FDA in March and hits the market just as eye complaints are soaring. Myopia is increasing so rapidly, an international study published in the journal Ophthalmology estimates half the global population could be nearsighted in the next thirty years. The EVO lenses take 8 to 10 minutes to implant and cost between $2,500 and $5,000 per eye. Because it is an elective surgery it is not generally covered by health insurance. For Robinson, the improvement in his vision was nearly immediate and he calls his new window on the world life-changing. “It’s pretty weird to wake up in the morning and just see,” he said. Other headlines:
The pandemic has brought a significant increase in vision complaints, partly fueled during the pandemic as people spent more time than ever staring at screens. The surge in nearsightedness, or myopia, is creating more interest in vision correction procedures and a recent innovation is attracting attention: an implantable contact lens, which was ideal for Powell Robinson, who has been using contact lenses since seventh grade.
“Basically, the inflammation from wearing them for super long hours made my vision get a little blurry, my eyes would get super dry, and it was just getting sort of unsustainable,” Robinson said.
Advertisement
Working as a cinematographer and director in Los Angeles, he went to Dr. Neda Shamie at the Malone-Shamie Vision Institute for help. She recommended a procedure known as EVO Visian ICL.
“The Evo ICL is a permanent implantable contact lens that’s placed in the eye instead of a contact lens that you would wear on the surface of the eye, where you have to constantly take out and put back in,” Shamie said.
She said that the implant is ideal for treating nearsightedness and offers an alternative to Lasik surgery, which works by changing the anatomy of the eye.
The Evo Visian ICL has been approved overseas for more than 10 years with more than a million surgeries performed. Here in the United States, it was approved by the FDA in March and hits the market just as eye complaints are soaring. Myopia is increasing so rapidly, an international study published in the journal Ophthalmology estimates half the global population could be nearsighted in the next thirty years.
The EVO lenses take 8 to 10 minutes to implant and cost between $2,500 and $5,000 per eye. Because it is an elective surgery it is not generally covered by health insurance. For Robinson, the improvement in his vision was nearly immediate and he calls his new window on the world life-changing.
“It’s pretty weird to wake up in the morning and just see,” he said.
Other headlines:
